Vedolizumab (anti-α4β7-integrin)

Product Name：Vedolizumab

CAS No.:   943609-66-3                               

Formula:  C₆₅₂₈H₁₀₀₇₂N₁₇₃₂O₂₀₄₂S₄₂                           

Molecular Weight： 147 kDa                   

Type:   Whole antibody                      

Target： Integrin α₄β₇
Antibody Form:  Purified immunoglobulin
Physical Form:  Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.
Description

ENTYVIO (vedolizumab), an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.

Biological Activity
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease

For research use only. Not for use in humans